IL-2 and IL-4 double knock-out mice reject islet allografts: A role for novel T-cell growth factors?

Saved in:
Bibliographic Details
Published inTransplantation proceedings Vol. 29; no. 1; pp. 1083 - 1084
Main Authors Roy-Chaudhury, P., Manfro, R.C., Steiger, J., Nickerson, P.W., Tian, Y., Zheng, X.X., Li, Y.S., Strom, T.B.
Format Journal Article Conference Proceeding
LanguageEnglish
Published New York, NY Elsevier Inc 01.02.1997
Elsevier Science
Subjects
Animals
Antibodies - therapeutic use
Biological and medical sciences
CD3 Complex - immunology
Diabetes Mellitus, Experimental - surgery
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Graft Rejection - immunology
Graft Rejection - pathology
Graft Survival
Immunosuppression - methods
Immunosuppressive Agents - therapeutic use
Interleukin-2 - genetics
Interleukin-2 - immunology
Interleukin-4 - genetics
Interleukin-4 - immunology
Islets of Langerhans Transplantation - immunology
Islets of Langerhans Transplantation - pathology
Lymphocyte Activation
Management. Various non-drug treatments. Langerhans islet grafts
Medical sciences
Mice
Mice, Inbred DBA
Mice, Knockout
Polyenes - therapeutic use
Sirolimus
Spleen - immunology
T-Lymphocytes - immunology
Transplantation, Homologous
Rejection
Vertebrata
Interleukin 4
Mammalia
Interleukin 2
Mouse
Animal
Cytokine
Rodentia
Langerhans islet
T-Lymphocyte
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0041-1345
1873-2623
DOI:10.1016/S0041-1345(96)00413-7